Difference between revisions of "Alendronate (Fosamax)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replace - "Class: " to "Class/mechanism: ")
Line 2: Line 2:
  
 
==General information==
 
==General information==
Class: Bisphosphonate, inhibits osteoclast activity, dissolution of hydroxyapatite crystals, and bone resorption/turnover.<ref name="insert">[http://www.merck.com/product/usa/pi_circulars/f/fosamax/fosamax_pi.pdf Alendronate (Fosamax) package insert]</ref><ref>[[Media:Alendronate.pdf | Alendronate (Fosamax) package insert (locally hosted backup)]]</ref>
+
Class/mechanism: Bisphosphonate, inhibits osteoclast activity, dissolution of hydroxyapatite crystals, and bone resorption/turnover.<ref name="insert">[http://www.merck.com/product/usa/pi_circulars/f/fosamax/fosamax_pi.pdf Alendronate (Fosamax) package insert]</ref><ref>[[Media:Alendronate.pdf | Alendronate (Fosamax) package insert (locally hosted backup)]]</ref>
 
<br>Route: PO
 
<br>Route: PO
 
<br>Extravasation: n/a
 
<br>Extravasation: n/a

Revision as of 17:03, 2 May 2013

Also known as (4-amino-1-hydroxy-1-phosphono-butyl)phosphonic acid, Adronat, alendronate sodium, alendronic acid, Alendros, Arendal, Fosamax+D, Fosamax plus D, Fosavance, Onclast.

General information

Class/mechanism: Bisphosphonate, inhibits osteoclast activity, dissolution of hydroxyapatite crystals, and bone resorption/turnover.[1][2]
Route: PO
Extravasation: n/a

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, Medscape, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Patient drug information

References